HEALTHWATCH - A new era in medicine as a FDA panel recommends approval for gene therapy in the fight against leukemia.
It’s the first treatment that would genetically alter a patient’s own cells to fight leukemia. It transforms the patient into what scientists call a living drug. University of Pennsylvania researchers developed the individualized treatment in which cells would be removed and shipped to a drug company, processed, and then sent back. Analysts predict individual costs could reach $300,000, but the treatment has been successful in scores of patients.
Segment Sponsored by: Mercy Health System